Mitochondrial SAM transporter deficiency disrupts heart maturation early in life by impairing vital metabolic pathways, according to a study published in Science Advances in August 2026. Researchers at the Karolinska Institutet discovered that disease progression in mouse models coincided precisely with the critical biological transition from milk to carbohydrate-rich solid foods, revealing a distinct metabolic vulnerability in the postnatal heart.
Postnatal Heart Development and Mitochondrial Vulnerability
The developing heart undergoes massive shifts in energy production and metabolic building blocks to keep pace with rapid growth. According to the study published in Science Advances (Vol. 12, Issue 35, eaeg8792), maintaining proper mitochondrial S-adenosylmethionine (SAM) availability and lipoylation is essential for successful heart maturation during infancy.
“Our results show that mitochondrial SAM availability and lipoylation are particularly important for heart maturation early in life,” says Anastasia Rumyantseva, a postdoctoral researcher at the Department of Medical Biochemistry and Biophysics at Karolinska Institutet and first author of the study.
Did you know? The infant heart relies heavily on fats for energy before transitioning to utilize diverse nutrients as solid foods are introduced into the diet. Disruptions in this metabolic window can trigger severe cardiac complications.
Dietary Intervention as a Potential Treatment Strategy
Because symptom onset closely tracked the dietary shift toward carbohydrates, the research team tested whether targeted nutritional support could alter disease progression. When the study’s mouse models received a diet enriched with medium-chain triglycerides—a specific category of fat—researchers observed measurable gains.
Both overall metabolism and heart tissue structure showed partial improvement following the intervention, and animal survival prolonged modestly. “Our findings suggest that it may be worthwhile exploring whether nutritional support tailored to a specific metabolic defect could be used as a treatment strategy,” says Anastasia Rumyantseva. “At the same time, it is important to note that the benefit was limited and that the results are based on a mouse model.”
Implications for Rare Mitochondrial Disorders
The newly identified mechanism provides a clearer framework for understanding rare mitochondrial disorders that target cardiac tissue. Investigators intend to determine if identical metabolic vulnerabilities exist within human heart cells and clinical populations managing related conditions.
Senior and contributing researchers involved in the work—alongside Rumyantseva—include T.S. Tippetts, A. Wilhalm, W. Carter, M. Moedas, F.A. Rosenberger, D. Moore, Á. Végvári, Y. Hinze, L. Muellner-Wong, D. Alsina, R. Wibom, R. Winston, T.P. Mathews, L.H. Lund, D.C. Andersson, G. Pironti, A. Wedell, R.J. DeBerardinis, C. Freyer, and A. Wredenberg.
Pro Tip for Researchers and Clinicians
When evaluating early-onset pediatric cardiomyopathies, investigating metabolic bottlenecks tied to mitochondrial co-factor synthesis and lipid utilization can reveal targeted nutritional entry points.
Frequently Asked Questions
What causes mitochondrial SAM transporter deficiency?
It is caused by genetic disruptions that impair the transport of S-adenosylmethionine into mitochondria, which subsequently disrupts essential processes like lipoylation required for heart metabolism.
Can diet cure mitochondrial heart defects?
No. While medium-chain triglyceride supplementation offered modest improvements in animal models, researchers emphasize that the benefits were limited and require extensive further study in humans.
What are the next steps for this research?
The team plans to evaluate whether human heart cells and patients with related rare mitochondrial diseases share the same metabolic vulnerabilities identified in the Karolinska Institutet study.
Join the Conversation: What are your thoughts on utilizing targeted nutritional support for metabolic heart conditions? Leave a comment below or explore more peer-reviewed research updates on our platform.
Worth a look